TrialClinical drug investigation2010

Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.

Steven G ChrysantPubMed ↗Publisher ↗

No numbers read from the abstract.